ImClone Systems

High Hopes and Altered Genes

By Kenneth Silber | October 1, 2009

Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...
Evan McCulloch of Franklin Biotechnology Discovery

By Staff Writer | February 10, 2003

S&P Rank: 3 Stars Strong Dose of Biotech
Michael Yellen of AIM Global Health Care Fund

By Staff Writer | January 31, 2003

S&P Rank: 4 Stars Good Prognoses for Drug Stocks

Advisor Tools

Business Evaluator

The Business Evaluator tool is designed to educate advisors on career options. Get recommendations unique to your situation as the Business Evaluator intuitively guides you through exploring a change.